Knowledge Library Prototype
Neurology Intelligence
Prototype collection covering stroke, epilepsy, migraine, neurodegenerative disorders, multiple sclerosis, neuropharmacology, FDA updates, clinical trials, and AJPPS research.
Featured AJPPS Research
AJPPS Research | Pilot Article
Cefepime-induced generalized tonic-clonic seizures in traumatic brain injury
Published: June 2026
Primary Mapping: Neurology Intelligence
Secondary Mapping: FDA Approvals & Medication Safety; Infectious Disease & Antimicrobial Stewardship
Tags: cefepime; seizures; neurotoxicity; traumatic brain injury; medication safety; antimicrobial therapy
This discovery record links readers to the official AJPPS article and does not republish the full article.
Latest Neurology Intelligence
Reserved for approved RSS/API content.
FDA & Regulatory Updates
- BsUFA IV: Fiscal Years 2028-2032
by FDA on 07/16/2026 at 5:00 pmOn September 30, 2022, the President signed into law the FDA User Fee Reauthorization Act of 2022.
- MantroForce - 729021 - 06/17/2026by FDA on 07/16/2026 at 4:35 pm
Unapproved New Drugs/Misbranded
- CDER Small Business & Industry Assistance (SBIA)by FDA on 07/16/2026 at 4:34 pm
A Comprehensive Resource for Information on Human Drug Development in Regulation
- Wholesale Peptide - 729447 - 06/17/2026by FDA on 07/16/2026 at 4:22 pm
Unapproved New Drugs/Misbranded
- Texinkart Inc. - 729046 - 06/17/2026by FDA on 07/16/2026 at 4:20 pm
Unapproved New Drugs/Misbranded
Clinical Trials Watch
Future ClinicalTrials.gov integration for neurological disorders.
Clinical Practice & Therapeutics
Future evidence summaries and guideline updates.
Related Collections
- Psychiatry Intelligence
- Pharmacogenomics Intelligence
- FDA Approvals & Medication Safety
- Infectious Disease & Antimicrobial Stewardship